Suppr超能文献

原发性喉淋巴瘤

Primary laryngeal lymphoma.

作者信息

Ansell S M, Habermann T M, Hoyer J D, Strickler J G, Chen M G, McDonald T J

机构信息

Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, U.S.A.

出版信息

Laryngoscope. 1997 Nov;107(11 Pt 1):1502-6. doi: 10.1097/00005537-199711000-00014.

Abstract

Primary laryngeal lymphoma is a very rare entity, with fewer than 50 cases reported in the English literature in the past 60 years. Close scrutiny of some of these case reports reveals that the larynx was not always the only site of involvement, thereby diminishing the total number of patients with primary laryngeal lymphoma to fewer than 35. The authors report a series of six patients, who were seen and evaluated at the Mayo Clinic between 1952 and 1995, with stage IAE non-Hodgkin's lymphoma of the larynx. Three patients had large-cell lymphomas according to the REAL (Revised European-American Lymphoid) classification. The other three had a small lymphocytic lymphoma, follicular small cleaved lymphoma, and follicular mixed lymphoma. All patients received radiation therapy alone as initial therapy for their disease and all patients had a complete remission to initial therapy. Four patients subsequently relapsed and the histology at relapse was the same as the initial histology in all four patients. Five patients have died, three of lymphoma, with a median survival of 67 months (range, 40 to 228 months). In view of the heterogeneity of histologies in this group of lymphomas, the variability in duration of response, and the significant number of patients who died of their disease, it is more likely that primary laryngeal lymphoma is an unusual presentation of non-Hodgkin's lymphoma than a separate disease entity. Despite the small number of patients in this study, the data would suggest that patients are best treated according to the histology of the lymphoma, rather than the limited stage and location of the disease.

摘要

原发性喉淋巴瘤是一种非常罕见的疾病,在过去60年的英文文献中报道的病例少于50例。仔细研究其中一些病例报告发现,喉部并不总是唯一受累部位,因此原发性喉淋巴瘤患者总数减少至不到35例。作者报告了一组6例患者,他们于1952年至1995年间在梅奥诊所接受诊治,均为IAE期喉非霍奇金淋巴瘤。根据REAL(修订的欧美淋巴瘤)分类,3例患者为大细胞淋巴瘤。另外3例分别为小淋巴细胞淋巴瘤、滤泡性小裂细胞淋巴瘤和滤泡性混合淋巴瘤。所有患者均接受单纯放疗作为疾病的初始治疗,且所有患者对初始治疗均完全缓解。4例患者随后复发,复发时的组织学与初始组织学相同。5例患者死亡,3例死于淋巴瘤,中位生存期为67个月(范围40至228个月)。鉴于这组淋巴瘤组织学的异质性、反应持续时间的变异性以及死于该病的患者数量众多,原发性喉淋巴瘤更可能是非霍奇金淋巴瘤的一种特殊表现,而非一种独立的疾病实体。尽管本研究中的患者数量较少,但数据表明,患者最好根据淋巴瘤的组织学进行治疗,而非根据疾病的局限期和部位。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验